Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial.
Joanna SuliburskaKatarzyna SkrypnikMonika SzulińskaJustyna KupszLeszek MarkuszewskiPaweł BogdańskiPublished in: Nutrients (2018)
Three-months of monotherapy with diuretics, Ca-antagonists, or ACE-I impairs zinc status in patients with newly diagnosed primary AH. Antihypertensive monopharmacotherapy and zinc metabolism alterations affect lipid metabolism, the oxidative state, and the inflammatory state.